Jim Cramer on Henry Schein: “I Think It’s a Good Stock”

Group 1 - Henry Schein, Inc. (NASDAQ:HSIC) is recognized for its strong financial performance, with a recent quarter showing surprising results, indicating it is a good stock to consider [1] - The company supplies healthcare products, equipment, and pharmaceuticals to dental and medical professionals, highlighting its role in the healthcare sector [2] - Evercore ISI has raised its price target for HSIC from $83 to $90 while maintaining an Outperform rating, citing signs of stabilization in the dental market and potential momentum from a new CEO announcement [2]